The Bulletin
The Times


.

Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets

  • Written by The Bulletin

SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc.

Read more: Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South...

hacklink zlibraryzlibraryz-libraryFanatikbetcasibomcasibomjojobetjustintvtaraftariumholiganbethacklink panelmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopgüvenilir casino siteleri